In Person Seminar: Deciphering the Metabolic Origins of Heart Failure: Towards Novel Therapeutic Targets
Daniel Kelly, Ph.D.
Willard and Rhoda Ware Professor
Director
Penn and CHOP Cardiovascular Institutes
Perelman School of Medicine
University of Pennsylvania
Children's Hospital of Philadelphia
Pioneers in Biomedical Research Seminar: Deciphering the Metabolic Origins of Heart Failure: Towards Novel Therapeutic Targets
Date: March 22, 2024
Time: 11 a.m. - 12 p.m.
In-person: Room G101 A/B, 4 Riverside Circle, Roanoke, Virginia
Virtual: Watch via Zoom
About this Seminar
During the development of heart failure, the myocardium undergoes fuel metabolic reprogramming that reduces the capacity for ATP production. This ultimately leads to an “energy starvation” that contributes to the pathogenesis of heart failure. The Kelly Lab has delineated the transcriptional regulatory circuitry that controls mitochondria function and fuel oxidation in the developing heart. In addition, metabolomic and proteomic profiling has identified nodal points for re-balancing the metabolic derangements of the failing heart. Dr. Kelly’s presentation will cover these topics.
Additional Details
This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Center for Vascular and Heart Research. The Pioneers in Biomedical Research Seminar Series, which runs annually from September to May, has featured leading biomedical researchers from throughout the country since the program began in 2012. The lectures are also open to all members of the Virginia Tech community including graduate students, undergraduates, faculty, and staff, as well as the public.
You May Also Be Interested In...
-
Home Item
Seminar: Precision Medicine of Biological Drugs for Brain Cancer , homeDec. 7, 2023, 11 a.m. | Professor, Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine | Seminar | Children's National Research and Innovation Campus
-
Home Item
In Person at CNRIC: Hyperactivation of an RNA Binding Protein by Cancer-associated Mutations , homeDec. 8, 2023, 11:00 a.m., Collaboratory, Children's National Research and Innovation Campus, Washington, D.C. | Daniel Dominguez, Ph.D., Assistant Professor, Pharmacology, UNC School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Group
-
Home Item
In Person Seminar: An Epigenome Atlas of the Embryonic Mouse Brain to Study Interneuron Neurogenesis in Normal Development and Disease Models , homeDec. 15, 2023, 11:00 a.m. | Timothy Petros, Ph.D., Investigator, Unit on Cellular and Molecular Neurodevelopment, Eunice Kennedy Shriver National Institute of Child Health & Human Development, National Institutes of Health | Co-Sponsored by the Fralin Biomedical Research Institute Center for Neurobiology Research
-
Home Item
In Person Seminar: Quantitative Proteomics for Understanding Epigenetic Cancer Mechanisms , homeJan. 12, 2024, 11 a.m. | Ben Garcia, Ph.D., Raymond H. Wittcoff Distinguished Professor and Head, Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine | Pioneers in Biomedical Research Seminar Series | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Group
-
Home Item
In Person Seminar: Building and Maintaining Biological Tubes , homeJan. 19, 2024, 11 a.m. | Ondine Cleaver, Ph.D., Professor, Molecular Biology, University of Texas Southwestern Medical Center | Pioneers in Biomedical Research Seminar Series | Co-Sponsored by the Fralin Biomedical Research Institute Center for Vascular and Heart Research
-
Home Item
Long Covid: the Lasting Legacy of the COVID-19 Pandemic , homeJan. 25, 2024, 5:30 p.m. (Reception at 5 p.m.) | Ziyad Al-Aly, M.D., FASN, Chief of Research and Development Service, Director, Clinical Epidemiology Center, VA St. Louis Health Care Systems | Maury Strauss Distinguished Public Lecture